Propyphenazone: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Propyphenazone-2d-skeletal.png|2D Skeletal Structure of Propyphenazone | |||
File:Saridon_von_Hoffmann-La_Roche.jpg|Saridon by Hoffmann-La Roche | |||
File:Propyphenazone_synthesis.svg|Synthesis of Propyphenazone | |||
</gallery> | |||
Latest revision as of 03:48, 18 February 2025
Propyphenazone is a derivative of phenazone with similar analgesic and antipyretic effects. It is used in combination with other substances such as paracetamol to enhance the pain-relieving effects. Propyphenazone is not widely used due to its potential for causing blood disorders.
History[edit]
Propyphenazone was first synthesized in the late 19th century and was used for many years as a common analgesic. However, it has been largely replaced by safer and more effective drugs.
Pharmacology[edit]
Propyphenazone is a non-steroidal anti-inflammatory drug (NSAID). It works by reducing the production of prostaglandins, chemicals that cause pain, fever, and inflammation.
Side Effects[edit]
The most common side effects of propyphenazone include nausea, vomiting, and stomach pain. In rare cases, it can cause serious blood disorders such as agranulocytosis and aplastic anemia.
Contraindications[edit]
Propyphenazone should not be used by people with a history of blood disorders, peptic ulcers, or allergic reactions to other NSAIDs. It should also be avoided during pregnancy and breastfeeding.
Legal Status[edit]
In some countries, propyphenazone is available over-the-counter, while in others it is a prescription-only medication. It has been banned in several countries due to its potential for causing blood disorders.


